A detailed history of Atlanta Consulting Group Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Atlanta Consulting Group Advisors, LLC holds 46,786 shares of PFE stock, worth $1.2 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
46,786
Previous 12,493 274.5%
Holding current value
$1.2 Million
Previous $350 Million 287.35%
% of portfolio
0.34%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$27.7 - $31.39 $949,916 - $1.08 Million
34,293 Added 274.5%
46,786 $1.35 Billion
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $26,775 - $31,376
1,060 Added 9.27%
12,493 $350 Million
Q1 2024

Aug 26, 2024

SELL
$25.89 - $29.73 $27,443 - $31,513
-1,060 Reduced 8.48%
11,433 $317 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $296,000 - $339,903
11,433 New
11,433 $317 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Atlanta Consulting Group Advisors, LLC Portfolio

Follow Atlanta Consulting Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlanta Consulting Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlanta Consulting Group Advisors, LLC with notifications on news.